BETA: Please send your feedback!

GlaxoSmithKline

LON: GSK-GB

Pharmaceuticals: Major

fair
$98.02bn
MEGA cap
£15.11 (1.08%)
GlaxoSmithKline Prices from the past year
14.2231%
since start of 2018
44.69
  • 5
  • 5
  • 5
  • -
  • 2
  • 3
  • 5
  • 4
  • 1
  • -
  • -
  • 5
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 1
  • 2
  • 3
  • 4
  • 5

About

GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.
website

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint 5
  • Pollution Prevention 5
  • Water Conservation 5
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety 2
  • Employee Ownership, Satisfaction, Benefits & Pay 3
  • Workplace Health and Safety 5
  • Integrity of Corporate Governance 4
  • Ethical Practices 1
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 5